| |
| |
|
| Insider
Information: |
Lehr Martin A. |
| Relationship: |
Chief Executive Office... |
| City: |
Philadelphia |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
159,701 |
|
|
Indirect Shares
|
820,190 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
979,891 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Context Therapeutics Inc. |
CNTX |
Chief Executive Office... |
2023-02-21 |
159,701 |
2023-02-21 |
820,190 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CNTX |
Context Therapeutics Inc. |
Chief Executive Officer |
• • – |
2023-02-21 |
4 |
AB |
$0.84 |
$4,900 |
D/D |
5,823 |
159,701 |
0 |
- |
|
| CNTX |
Context Therapeutics Inc. |
Chief Executive Officer |
• • – |
2023-02-13 |
4 |
AB |
$0.87 |
$4,901 |
D/D |
5,606 |
153,878 |
0 |
- |
|
| CNTX |
Context Therapeutics Inc. |
Chief Executive Officer |
• • – |
2023-02-06 |
4 |
AB |
$0.97 |
$4,900 |
D/D |
5,040 |
148,272 |
0 |
- |
|
| CNTX |
Context Therapeutics Inc. |
Chief Executive Officer |
• • – |
2023-01-30 |
4 |
AB |
$0.70 |
$4,901 |
D/D |
7,027 |
143,232 |
0 |
- |
|
| CNTX |
Context Therapeutics Inc. |
Chief Executive Officer |
• • – |
2023-01-23 |
4 |
AB |
$0.72 |
$4,901 |
D/D |
6,839 |
136,205 |
0 |
- |
|
| CNTX |
Context Therapeutics Inc. |
Chief Executive Officer |
• • – |
2023-01-17 |
4 |
AB |
$0.74 |
$4,995 |
D/D |
6,783 |
129,366 |
0 |
- |
|
| CNTX |
Context Therapeutics Inc. |
Chief Executive Officer |
• • – |
2022-12-16 |
4 |
B |
$0.74 |
$14,796 |
D/D |
20,000 |
122,583 |
2.81 |
- |
|
| CNTX |
Context Therapeutics Inc. |
Chief Executive Officer |
• • – |
2022-08-19 |
4 |
B |
$1.85 |
$24,064 |
D/D |
13,000 |
102,583 |
2.81 |
- |
|
| CNTX |
Context Therapeutics Inc. |
Chief Executive Officer |
• • – |
2021-12-16 |
4 |
B |
$3.22 |
$41,850 |
I/I |
13,000 |
820,190 |
2.66 |
- |
|
| CNTX |
Context Therapeutics Inc. |
Chief Executive Officer |
• • – |
2021-10-22 |
4/A |
B |
$5.00 |
$50,000 |
I/I |
10,000 |
807,190 |
2.66 |
- |
|
| CNTX |
Context Therapeutics Inc. |
Chief Executive Officer |
• • – |
2021-10-22 |
4/A |
A |
$0.00 |
$0 |
I/I |
797,190 |
797,190 |
0 |
- |
|
| CNTX |
Context Therapeutics Inc. |
Chief Executive Officer |
• • – |
2021-10-22 |
4/A |
A |
$7.14 |
$376,135 |
I/I |
52,680 |
0 |
0 |
- |
|
| CNTX |
Context Therapeutics Inc. |
Chief Executive Officer |
• • – |
2021-10-22 |
4 |
A |
$0.00 |
$0 |
I/I |
797,198 |
849,878 |
0 |
- |
|
| CNTX |
Context Therapeutics Inc. |
Chief Executive Officer |
• • – |
2021-10-22 |
4 |
A |
$7.14 |
$376,135 |
I/I |
52,680 |
52,680 |
0 |
- |
|
| CNTX |
Context Therapeutics Inc. |
Chief Executive Officer |
• • – |
2021-10-22 |
4 |
B |
$5.00 |
$50,000 |
D/D |
10,000 |
99,583 |
2.81 |
- |
|
| CNTX |
Context Therapeutics Inc. |
Chief Executive OfficerOfficer |
• • – |
2021-10-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
89,583 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
